Table of Contents
Cardiovascular Psychiatry and Neurology
Volume 2010 (2010), Article ID 790431, 7 pages
http://dx.doi.org/10.1155/2010/790431
Review Article

Adipocytes as an Important Source of Serum S100B and Possible Roles of This Protein in Adipose Tissue

Departamento de Bioquímica, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Ramiro Barcelos, 2600-Anexo, 90035-003 Porto Alegre, RS, Brazil

Received 1 April 2010; Accepted 17 May 2010

Academic Editor: Claus W. Heizmann

Copyright © 2010 Carlos Alberto Gonçalves et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. M. Bloomfield, J. McKinney, L. Smith, and J. Brisman, “Reliability of S100B in predicting severity of central nervous system injury,” Neurocritical Care, vol. 6, no. 2, pp. 121–138, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. J. Sen and A. Belli, “S100B in neuropathologic states: the CRP of the brain?” Journal of Neuroscience Research, vol. 85, no. 7, pp. 1373–1380, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. M. Rothermundt, M. Peters, J. H. Prehn, and V. Arolt, “S100B in brain damage and neurodegeneration,” Microscopy Research and Technique, vol. 60, no. 6, pp. 614–632, 2003. View at Google Scholar · View at Scopus
  4. P. Dassan, G. Keir, and M. M. Brown, “Criteria for a clinically informative serum biomarker in acute ischaemic stroke: a review of S100B,” Cerebrovascular Diseases, vol. 27, no. 3, pp. 295–302, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. C.-A. Gonçalves, M. Concli Leite, and P. Nardin, “Biological and methodological features of the measurement of S100B, a putative marker of brain injury,” Clinical Biochemistry, vol. 41, no. 10-11, pp. 755–763, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. A. Kleindienst and M. R. Bullock, “A critical analysis of the role of the neurotrophic protein S100B in acute brain injury,” Journal of Neurotrauma, vol. 23, no. 8, pp. 1185–1200, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. D. B. Hausman, M. DiGirolamo, T. J. Bartness, G. J. Hausman, and R. J. Martin, “The biology of white adipocyte proliferation,” Obesity Reviews, vol. 2, no. 4, pp. 239–254, 2001. View at Google Scholar · View at Scopus
  8. E. E. Kershaw and J. S. Flier, “Adipose tissue as an endocrine organ,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 6, pp. 2548–2556, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. M. Blüher, “Adipose tissue dysfunction in obesity,” Experimental and Clinical Endocrinology and Diabetes, vol. 117, no. 6, pp. 241–250, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. B. W. Moore, “A soluble protein characteristic of the nervous system,” Biochemical and Biophysical Research Communications, vol. 19, no. 6, pp. 739–744, 1965. View at Google Scholar · View at Scopus
  11. B. E. Boyes, S. U. Kim, V. Lee, and S. C. Sung, “Immunohistochemical co-localization of S-100b and the glial fibrillary acidic protein in rat brain,” Neuroscience, vol. 17, no. 3, pp. 857–865, 1986. View at Google Scholar · View at Scopus
  12. J. Steiner, H.-G. Bernstein, and H.-G. Bernstein, “Evidence for a wide extra-astrocytic distribution of S100B in human brain,” BMC Neuroscience, vol. 8, article 2, 2007. View at Publisher · View at Google Scholar · View at PubMed
  13. C. Adami, G. Sorci, E. Blasi, A. L. Agneletti, F. Bistoni, and R. Donato, “S100B expression in and effects on microglia,” Glia, vol. 33, no. 2, pp. 131–142, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. Q. Yang, A. Hamberger, H. Hyden, S. Wang, T. Stigbrand, and K. G. Haglid, “S-100β has a neuronal localisation in the rat hindbrain revealed by an antigen retrieval method,” Brain Research, vol. 696, no. 1-2, pp. 49–61, 1995. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Haimoto, S. Hosoda, and K. Kato, “Differential distribution of immunoreactive S100-α and S100-β proteins in normal nonnervous human tissues,” Laboratory Investigation, vol. 57, no. 5, pp. 489–498, 1987. View at Google Scholar · View at Scopus
  16. D. B. Zimmer and L. J. Van Eldik, “Tissue distribution of rat S100α and S100β and S100-binding proteins,” American Journal of Physiology, vol. 252, no. 3, pp. C285–C289, 1987. View at Google Scholar · View at Scopus
  17. F. Michetti, E. Dell'Anna, G. Tiberio, and D. Cocchia, “Immunochemical and immunocytochemical study of S-100 protein in rat adipocytes,” Brain Research, vol. 262, no. 2, pp. 352–356, 1983. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Stefansson, R. L. Wollmann, B. W. Moore, and B. G. W. Arnason, “S-100 protein in human chondrocytes,” Nature, vol. 295, no. 5844, pp. 63–64, 1982. View at Google Scholar · View at Scopus
  19. D. Cocchia, F. Michetti, and R. Donato, “Immunochemical and immuno-cytochemical localization of S-100 antigen in normal human skin,” Nature, vol. 294, no. 5836, pp. 85–87, 1981. View at Google Scholar · View at Scopus
  20. H. Hidaka, T. Endo, S. Kawamoto, E. Yamada, H. Umekawa, K. Tanabe, and K. Hara, “Purification and characterization of adipose tissue S-100b protein,” Journal of Biological Chemistry, vol. 258, no. 4, pp. 2705–2709, 1983. View at Google Scholar · View at Scopus
  21. D. B. Zimmer, W. Song, and W. E. Zimmer, “Isolation of a rat S100α cDNA and distribution of its mRNA in rat tissues,” Brain Research Bulletin, vol. 27, no. 2, pp. 157–162, 1991. View at Publisher · View at Google Scholar · View at Scopus
  22. D. B. Zimmer, J. Chessher, G. L. Wilson, and W. E. Zimmer, “S100A1 and S100B expression and target proteins in type I diabetes,” Endocrinology, vol. 138, no. 12, pp. 5176–5183, 1997. View at Google Scholar · View at Scopus
  23. D. B. Zimmer, E. H. Cornwall, A. Landar, and W. Song, “The S100 protein family: history, function, and expression,” Brain Research Bulletin, vol. 37, no. 4, pp. 417–429, 1995. View at Publisher · View at Google Scholar · View at Scopus
  24. A. M. Feoli, M. C. Leite, and M. C. Leite, “Developmental changes in content of glial marker proteins in rats exposed to protein malnutrition,” Brain Research, vol. 1187, no. 1, pp. 33–41, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. M. C. Leite, F. Galland, and F. Galland, “A simple, sensitive and widely applicable ELISA for S100B: methodological features of the measurement of this glial protein,” Journal of Neuroscience Methods, vol. 169, no. 1, pp. 93–99, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. L. Rodrigues, R. Biasibetti, and R. Biasibetti, “Hippocampal alterations in rats submitted to streptozotocin-induced dementia model are prevented by aminoguanidine,” Journal of Alzheimer's Disease, vol. 17, no. 1, pp. 193–202, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. F. Suzuki, K. Kato, and T. Nakajima, “Enhancement of adipose S-100 protein release by catecholamines,” Journal of Biochemistry, vol. 94, no. 5, pp. 1707–1710, 1983. View at Google Scholar
  28. K. Kato, F. Suzuki, and T. Nakajima, “S-100 protein in adipose tissue,” International Journal of Biochemistry, vol. 15, no. 5, pp. 609–613, 1983. View at Publisher · View at Google Scholar
  29. F. Suzuki, K. Kato, and T. Nakajima, “Regulation of nervous system-specific S-100 protein and enolase levels in adipose tissue by catecholamines,” Journal of Neurochemistry, vol. 42, no. 1, pp. 130–134, 1984. View at Google Scholar
  30. F. Suzuki, K. Kato, and T. Nakajima, “Hormonal regulation of adipose S-100 protein release,” Journal of Neurochemistry, vol. 43, no. 5, pp. 1336–1341, 1984. View at Google Scholar
  31. F. Suzuki and K. Kato, “Inhibition of adipose S-100 protein release by insulin,” Biochimica et Biophysica Acta, vol. 845, no. 2, pp. 311–316, 1985. View at Publisher · View at Google Scholar
  32. F. Suzuki and K. Kato, “Induction of adipose S-100 protein release by free fatty acids in adipocytes,” Biochimica et Biophysica Acta, vol. 889, no. 1, pp. 84–90, 1986. View at Google Scholar
  33. C. B. O. Netto, S. Conte, and S. Conte, “Serum S100B protein is increased in fasting rats,” Archives of Medical Research, vol. 37, no. 5, pp. 683–686, 2006. View at Publisher · View at Google Scholar · View at PubMed
  34. G. Ghanem, B. Loir, R. Morandini, F. Sales, D. Lienard, A. Eggermont, and F. Lejeune, “On the release and half-life of S100B protein in the peripheral blood of melanoma patients,” International Journal of Cancer, vol. 94, no. 4, pp. 586–590, 2001. View at Publisher · View at Google Scholar · View at PubMed
  35. S. S. Pinto, C. Gottfried, and C. Gottfried, “Immunocontent and secretion of S100B in astrocyte cultures from different brain regions in relation to morphology,” FEBS Letters, vol. 486, no. 3, pp. 203–207, 2000. View at Publisher · View at Google Scholar
  36. M. O. Dietrich, A. B. Tort, D. V. Schaf, M. Farina, C. A. Gonçalves, D. O. Souza, and L. V. Portela, “Increase in serum S100B protein level after a swimming race,” Canadian Journal of Applied Physiology, vol. 28, no. 5, pp. 710–716, 2003. View at Google Scholar
  37. M. Hasselblatt, F. C. Mooren, and F. C. Mooren, “Serum S100β increases in marathon runners reflect extracranial release rather than glial damage,” Neurology, vol. 62, no. 9, pp. 1634–1636, 2004. View at Google Scholar
  38. K. H. Schulpis, M. Moukas, T. Parthimos, T. Tsakiris, N. Parthimos, and S. Tsakiris, “The effect of α-Tocopherol supplementation on training-induced elevation of S100B protein in sera of basketball players,” Clinical Biochemistry, vol. 40, no. 12, pp. 900–906, 2007. View at Publisher · View at Google Scholar · View at PubMed
  39. A. C. Andreazza, C. Cassini, and C. Cassini, “Serum S100B and antioxidant enzymes in bipolar patients,” Journal of Psychiatric Research, vol. 41, no. 6, pp. 523–529, 2007. View at Publisher · View at Google Scholar · View at PubMed
  40. S. Ehrlich, H. Salbach-Andrae, and H. Salbach-Andrae, “S100B in underweight and weight-recovered patients with anorexia nervosa,” Psychoneuroendocrinology, vol. 33, no. 6, pp. 782–788, 2008. View at Publisher · View at Google Scholar · View at PubMed
  41. K. Holtkamp, K. Bühren, G. Ponath, C. von Eiff, B. Herpertz-Dahlmann, J. Hebebrand, and M. Rothermundt, “Serum levels of S100B are decreased in chronic starvation and normalize with weight gain,” Journal of Neural Transmission, vol. 115, no. 6, pp. 937–940, 2008. View at Publisher · View at Google Scholar · View at PubMed
  42. J. Steiner, K. Schiltz, and K. Schiltz, “S100B serum levels are closely correlated with body mass index: an important caveat in neuropsychiatric research,” Psychoneuroendocrinology, vol. 35, pp. 321–324, 2009. View at Publisher · View at Google Scholar · View at PubMed
  43. L. Reshef, Y. Olswang, and Y. Olswang, “Glyceroneogenesis and the triglyceride/fatty acid cycle,” Journal of Biological Chemistry, vol. 278, no. 33, pp. 30413–30416, 2003. View at Publisher · View at Google Scholar · View at PubMed
  44. A. Landar, G. Caddell, J. Chessher, and D. B. Zimmer, “Identification of an S100A1/S100B target protein: phosphoglucomutase,” Cell Calcium, vol. 20, no. 3, pp. 279–285, 1996. View at Publisher · View at Google Scholar
  45. D. B. Zimmer and L. J. Van Eldik, “Identification of a molecular target for the calcium-modulated protein S100. Fructose-1,6-bisphosphate aldolase,” Journal of Biological Chemistry, vol. 261, no. 24, pp. 11424–11428, 1986. View at Google Scholar
  46. D. Gonçalves, J. Karl, and J. Karl, “High glutamate decreases S100B secretion stimulated by serum deprivation in astrocytes,” NeuroReport, vol. 13, no. 12, pp. 1533–1535, 2002. View at Google Scholar
  47. G. Hagens, I. Masouyé, E. Augsburger, R. Hotz, J.-H. Saurat, and G. Siegenthaler, “Calcium-binding protein S100A7 and epidermal-type fatty acid-binding protein are associated in the cytosol of human keratinocytes,” Biochemical Journal, vol. 339, part 2, pp. 419–427, 1999. View at Publisher · View at Google Scholar
  48. K. Roulin, G. Hagens, R. Hotz, J.-H. Saurat, J. H. Veerkamp, and G. Siegenthaler, “The fatty acid-binding heterocomplex FA-p34 formed by S100A8 and S100A9 is the major fatty acid carrier in neutrophils and translocates from the cytosol to the membrane upon stimulation,” Experimental Cell Research, vol. 247, no. 2, pp. 410–421, 1999. View at Publisher · View at Google Scholar · View at PubMed
  49. R. Donato, G. Sorci, and G. Sorci, “S100B's double life: intracellular regulator and extracellular signal,” Biochimica et Biophysica Acta, vol. 1793, no. 6, pp. 1008–1022, 2009. View at Publisher · View at Google Scholar · View at PubMed
  50. E. Leclerc, G. Fritz, M. Weibel, C. W. Heizmann, and A. Galichet, “S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains,” Journal of Biological Chemistry, vol. 282, no. 43, pp. 31317–31331, 2007. View at Publisher · View at Google Scholar · View at PubMed
  51. J. V. Valencia, M. Mone, J. Zhang, M. Weetall, F. P. Buxton, and T. E. Hughes, “Divergent pathways of gene expression are activated by the RAGE ligands S100b and AGE-BSA,” Diabetes, vol. 53, no. 3, pp. 743–751, 2004. View at Publisher · View at Google Scholar
  52. E. Leclerc, G. Fritz, S. W. Vetter, and C. W. Heizmann, “Binding of S100 proteins to RAGE: an update,” Biochimica et Biophysica Acta, vol. 1793, no. 6, pp. 993–1007, 2009. View at Publisher · View at Google Scholar · View at PubMed
  53. R. Donato, “RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins,” Current Molecular Medicine, vol. 7, no. 8, pp. 711–724, 2007. View at Publisher · View at Google Scholar
  54. T. Ostendorp, E. Leclerc, and E. Leclerc, “Structural and functional insights into RAGE activation by multimeric S100B,” The EMBO Journal, vol. 26, no. 16, pp. 3868–3878, 2007. View at Publisher · View at Google Scholar · View at PubMed
  55. H. Unoki, H. Bujo, S.-I. Yamagishi, M. Takeuchi, T. Imaizumi, and Y. Saito, “Advanced glycation end products attenuate cellular insulin sensitivity by increasing the generation of intracellular reactive oxygen species in adipocytes,” Diabetes Research and Clinical Practice, vol. 76, no. 2, pp. 236–244, 2007. View at Publisher · View at Google Scholar · View at PubMed
  56. N. Shanmugam, Y. S. Kim, L. Lanting, and R. Natarajan, “Regulation of cyclooxygenase-2 expression in monocytes by ligation of the receptor for advanced glycation end products,” Journal of Biological Chemistry, vol. 278, no. 37, pp. 34834–34844, 2003. View at Publisher · View at Google Scholar · View at PubMed
  57. G. Esposito, D. De Filippis, C. Cirillo, G. Sarnelli, R. Cuomo, and T. Iuvone, “The astroglial-derived S100β protein stimulates the expression of nitric oxide synthase in rodent macrophages through p38 MAP kinase activation,” Life Sciences, vol. 78, no. 23, pp. 2707–2715, 2006. View at Publisher · View at Google Scholar · View at PubMed
  58. L. Feng, C. Matsumoto, A. Schwartz, A. M. Schmidt, D. M. Stern, and J. Pile-Spellman, “Chronic vascular inflammation in patients with type 2 diabetes: endothelial biopsy and RT-PCR analysis,” Diabetes Care, vol. 28, no. 2, pp. 379–384, 2005. View at Publisher · View at Google Scholar
  59. X. Gao, H. Zhang, A. M. Schmidt, and C. Zhang, “AGE/RAGE produces endothelial dysfunction in coronary arterioles in type 2 diabetic mice,” American Journal of Physiology, vol. 295, no. 2, pp. H491–H498, 2008. View at Publisher · View at Google Scholar · View at PubMed
  60. L. C. Ribeiro, A. L. Chittó, and A. L. Chittó, “Ketogenic diet-fed rats have increased fat mass and phosphoenolpyruvate carboxykinase activity,” Molecular Nutrition and Food Research, vol. 52, no. 11, pp. 1365–1371, 2008. View at Publisher · View at Google Scholar · View at PubMed
  61. M. A. Hofmann, S. Drury, and S. Drury, “RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides,” Cell, vol. 97, no. 7, pp. 889–901, 1999. View at Publisher · View at Google Scholar
  62. H. Tilg and A. R. Moschen, “Adipocytokines: mediators linking adipose tissue, inflammation and immunity,” Nature Reviews Immunology, vol. 6, no. 10, pp. 772–783, 2006. View at Publisher · View at Google Scholar · View at PubMed
  63. J. N. Tsoporis, F. Mohammadzadeh, and T. G. Parker, “S100B: a multifunctional role in cardiovascular pathophysiology,” Amino Acids. In press. View at Publisher · View at Google Scholar · View at PubMed
  64. J. N. Tsoporis, C. B. Overgaard, S. Izhar, and T. G. Parker, “S100B modulates the hemodynamic response to norepinephrine stimulation,” American Journal of Hypertension, vol. 22, no. 10, pp. 1048–1053, 2009. View at Publisher · View at Google Scholar · View at PubMed
  65. M. E. Bianchi, “DAMPs, PAMPs and alarmins: all we need to know about danger,” Journal of Leukocyte Biology, vol. 81, no. 1, pp. 1–5, 2007. View at Publisher · View at Google Scholar · View at PubMed
  66. R. E. Andersen, L.-O. Hansson, O. Nilsson, R. Dijlai-Merzoug, and G. Settergren, “High serum S100b levels for trauma patients without head injuries,” Neurosurgery, vol. 48, no. 6, pp. 1255–1260, 2001. View at Google Scholar
  67. U. Missler, N. Orlowski, A. Nötzold, L. Dibbelt, E. Steinmeier, and M. Wiesmann, “Early elevation of S-100B protein in blood after cardiac surgery is not a predictor of ischemic cerebral injury,” Clinica Chimica Acta, vol. 321, no. 1-2, pp. 29–33, 2002. View at Publisher · View at Google Scholar
  68. R. Harpio and R. Einarsson, “S100 proteins as cancer biomarkers with focus on S100B in malignant melanoma,” Clinical Biochemistry, vol. 37, no. 7, pp. 512–518, 2004. View at Publisher · View at Google Scholar · View at PubMed
  69. D. M. Huffman and N. Barzilai, “Role of visceral adipose tissue in aging,” Biochimica et Biophysica Acta, vol. 1790, no. 10, pp. 1117–1123, 2009. View at Publisher · View at Google Scholar · View at PubMed
  70. J. A. Luchsinger and D. R. Gustafson, “Adiposity, type 2 diabetes, and Alzheimer's disease,” Journal of Alzheimer's Disease, vol. 16, no. 4, pp. 693–704, 2009. View at Publisher · View at Google Scholar · View at PubMed
  71. M. Jakovljević, Ž. Crnčević, D. Ljubičić, D. Babić, R. Topić, and M. Šarić, “Mental disorders and metabolic syndrome: a fatamorgana or warning reality?” Psychiatria Danubina, vol. 19, no. 1-2, pp. 76–86, 2007. View at Google Scholar
  72. M. L. Schroeter and J. Steiner, “Elevated serum levels of the glial marker protein S100B are not specific for schizophrenia or mood disorders,” Molecular Psychiatry, vol. 14, no. 3, pp. 235–237, 2009. View at Publisher · View at Google Scholar · View at PubMed
  73. J. Steiner, M. Walter, and M. Walter, “Elevated S100B levels in schizophrenia are associated with insulin resistance,” Molecular Psychiatry, vol. 15, no. 1, pp. 3–4, 2010. View at Publisher · View at Google Scholar · View at PubMed
  74. L. V. C. Portela, A. B. L. Tort, and A. B. L. Tort, “The serum S100B concentration is age dependent,” Clinical Chemistry, vol. 48, no. 6, pp. 950–952, 2002. View at Google Scholar
  75. F. Tramontina, S. Conte, and S. Conte, “Developmental changes in S100B content in brain tissue, cerebrospinal fluid, and astrocyte cultures of rats,” Cellular and Molecular Neurobiology, vol. 22, no. 3, pp. 373–378, 2002. View at Publisher · View at Google Scholar
  76. G. Barbatelli, M. Morroni, P. Vinesi, S. Cinti, and F. Michetti, “S-100 protein in rat brown adipose tissue under different functional conditions: a morphological, immunocytochemical, and immunochemical study,” Experimental Cell Research, vol. 208, no. 1, pp. 226–231, 1993. View at Publisher · View at Google Scholar · View at PubMed
  77. M. P. Mattson, “Perspective: does brown fat protect against diseases of aging?” Ageing Research Reviews, vol. 9, no. 1, pp. 69–76, 2010. View at Publisher · View at Google Scholar · View at PubMed